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Objective: Compare the effectiveness of ultrasound and fluoroscopy to guide intra-articular 
injections (IAI) in selected cases.
Material and methods: A prospective study in our outpatient clinics at the Rheumatology 
Division at Universidade Federal de São Paulo (UNIFESP), Brazil, was conducted to compare 
the short-term (4 weeks) effectiveness of ultrasound and fluoroscopy-guided IAI in patients 
with rheumatic diseases. Inclusion criteria were: adults with refractory synovitis undergo-
ing IAI with glucocorticoid. All patients had IAI performed with triamcinolone hexaceton-
ide (20mg/ml) with varying doses according to the joint injected.
Results: A total of 71 rheumatic patients were evaluated (52 women, 44 whites). Mean age 
was 51.9 ± 13 years and 47 of them (66.2%) were on regular DMARD use. Analysis of the 
whole sample (71 patients) and hip sub-analysis (23 patients) showed that significant im-
provement was observed for both groups in terms of pain (P < 0.001). Global analysis also 
demonstrated better outcomes for patients in the FCG in terms of joint flexion (P < 0.001) 
and percentage change in joint flexion as compared to the USG. Likert scale score analyses 
demonstrated better results for the patients in the USG as compared to the FCG at the end 
of the study (P < 0.05). No statistically significant difference between groups was observed 
for any other study variable.
Discussion and conclusion: Imaging-guided IAI improves regional pain in patients with vari-
ous types of synovitis in the short term. For the vast majority of variables, no significant 
difference in terms of effectiveness was observed between fluoroscopy and ultrasound-
guided IAI.
© 2013 Elsevier Editora Ltda. All rights reserved.
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Efetividade da infiltração intra-articular guiada por imagem: comparação 
entre fluoroscopia e ultrassom
Palavras-chave:
Injeção intra-articular
Fluoroscopia
Ultrassonografia
r e s u m o
Objetivos: Comparar a curto prazo (04 semanas) a efetividade das infiltrações intra-articu-
lares (IIA) guiadas por fluoroscopia (FC) e ultrassom (US) em pacientes com enfermidades 
reumáticas.
Material e métodos: Foi realizado um estudo controlado e prospectivo em pacientes porta-
dores de doenças reumáticas captados dos ambulatórios da Disciplina de Reumatologia 
da Universidade Federal de São Paulo (UNIFESP), Brasil. Critério de inclusão: adultos com 
indicação de IIA com corticosteróide por sinovite refratária. Todos os pacientes forma infil-
trados com hexacetonide triancinolona (20 mg/mL) com doses variáveis, de acordo com a 
articulação estudada.
Resultados: Foram avaliados 71 pacientes (52 mulheres; 44 brancos), portadores de enfermi-
dades reumáticas variadas. A média de idade era 51,9 ± 13 anos e 47 deles (66,2%) faziam 
uso de drogas modificadora do curso da doença (DMARD). Na análise global da amostra 
(71 pacientes) e na subanálise coxofemoral (23 pacientes), observou-se melhora estatística 
(p < 0,001) em ambos os grupos quanto à EVA de dor. Na análise global observou-se au-
mento significativo da flexão articular (p < 0,001) e um Δ de flexão maior a favor do grupo 
guiado por FC. A avaliação de melhora segundo Likert Scale mostrou diferença significativa 
(p < 0,05) entre os grupos na avaliação global, nas proporções inalterado e melhor, a favor 
do grupo guiado por US. Não foi observada diferença estatisticamente significante entre os 
grupos para qualquer outra variável.
Conclusão: A IIA guiada por imagem melhorou a dor regional, a curto prazo, relacionada à 
sinovite de vários tipos de articulações. Para a grande maioria das variáveis avaliadas não 
houve diferença entre a efetividade da IIA guiada por US ou FC.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Introduction
Intra-articular injections (IAI) with glucocorticoids have 
been used for more than half a century for the treatment of 
refractory articular disorders either as monotherapy or as-
sociated with systemic interventions in multiple rheumatic 
conditions. Nevertheless, the efficacy of IAI is often ques-
tioned and part of the controversy might be related to its 
low accuracy when performed as a blind procedure by inex-
perienced physicians or in joints with very difficult access 
techniques.1,2
Imaging methods easily available, such as ultrasound and 
fluoroscopy can be used to guide IAI and improve its accu-
racy,3 especially in deep joints with the greatest chance of 
technical error, such as the hip.4 Other imaging methods such 
as computed tomography (CT) and magnetic resonance imag-
ing (MRI) can also be used for this purpose, but are much less 
available for clinical use.
Fluoroscopy is often used to guide IAI in joints with dif-
ficult access. Its use in glenohumeral approach was first de-
scribed in 1933 by Oberholzer and modified by Schneider.5 
One of its advantages is related to the fact that it is found in 
most hospitals, and therefore the technique is easily avail-
able, unlike CT and MRI scans. Technological advances have 
made fluoroscopy able to reproduce high resolution images 
using less radiation. New generations of these devices are 
more compact, portable and easy to handle.6
Ultrasound (US) is usually practical and safe to evaluate 
intra-articular structures (synovium, cartilage and subchon-
dral bone)7 and soft tissue involvement in rheumatic diseases. 
Intra and periarticular corticosteroid ultrasound-guided IAI is 
quick, safe and reduces the risk of injury to the cartilage, ten-
don, nerve and/or vessels.2 Its safety and practical issues have 
made most rheumatologists prone to accept the technique in 
their clinical practices. 
In spite of their broad use to guide IAI, these methods (flu-
oroscopy and ultrasound) are different in terms of cost, safety, 
training curve, interface with other medical specialties, and 
usefulness in the management of periarticular structures.5 
The best imaging technique to guide IAI has not been defined 
since there are no studies comparing the cost-effectiveness 
of these methods in a controlled manner. The purpose of the 
present study is to compare fluoroscopy and ultrasound in 
terms of their effectiveness to guide IAI with corticosteroids.
Material and methods 
Patients
A single blind controlled prospective study was conducted 
with 71 consecutive patients from the outpatient clinics of 
the Rheumatology Division at the Federal University of São 
Paulo, Escola Paulista de Medicina, São Paulo, Brazil. The study 
was approved by the ethics committee of the Institution.
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This study aimed to compare the short term effectiveness 
of ultrasound versus fluoroscopy-guided IAI in patients with 
refractory synovitis caused by either autoimmune or degen-
erative disorders.
The sample size of 24 individuals in each group was con-
sidered appropriate, once the VAS (visual analogue scale) for 
pain was the most important primary outcome of the study. 
In order to calculate the study size we used a standard devia-
tion 2.0, a power of 80%, and a 5% significance level. 
To participate in the study, the patient should meet the fol-
lowing inclusion criteria: IAI indication due to synovitis with 
duration of at least one month, and age between 18-65 years-
old. Patients with uncontrolled hypertension or diabetes mel-
litus; damage of any kind to the skin site to be punctured; sus-
pected infection, severe clotting disorder, and known allergy 
to contrast media were all excluded from the study.
Intervention
Convenience non-random sampling was used and the pa-
tients were divided into two intervention groups, according to 
the imaging technique available to guide the procedure: fluo-
roscopy group (FCG) and ultrasound group (USG).
All IAI were performed by a physician experienced in mus-
culoskeletal intervention. Triamcinolone hexacetonide (TH) 
was used in all procedures. HT doses varied according to the 
size of the joint (20-100 mg; 1-5 mL). Hips were systematically 
injected with HT 100 mg.
For both groups, sterile material and gloves were used and 
2% lidocaine was injected in the intra-articular space. In USG 
patients, IAI followed the technique of insertion of the needle 
parallel with respect to the transducer2 using a sterile shield 
to cover it. In patients in the FCG, iobitriol contrast medium 
was applied to certify the intra-articular positioning of the 
needle before injecting HT.
All patients were instructed to maintain joint rest after in-
jection for 48 hours without weight bearing activities.
Evaluation and outcomes
Patients were evaluated by an examiner “blind” to the pro-
cedures at two time points: T0 (before intervention) and T4 
(04 weeks after intervention) and the following assessment 
measures were performed:
r7"4	WJTVBMBOBMPHVFTDBMFDN
GPSQBJO
r *NQSPWFNFOU -JLFSU QPJOU TDBMF 	NVDIXPSTF TPNF-
what worse, unchanged, better, much better);
r+PJOUáFYJPONFBTVSFECZHPOJPNFUSZ
r1FSDFOUBHFDIBOHFGPSKPJOUáFYJPO	ĴàOBMáFYJPOJOJ-
tial flexion / initial flexion × 100);
Statistical analsys
The software SPSS 17.0 was used for statistical analysis. In 
order to asses normatility of data in SPSS, it was used the Sha-
piro-Wilk test. Chi-squared test was used for the analysis of 
categorical variables. Student’s t test was used for the analy-
sis of numerical variables. ANOVA for repeated measures was 
used for the intergroup and intragroup analyses. The signifi-
cance level was set as P < 0.05.
Results
A total of 71 patients underwent imaging-guided IAI as shown 
in Table 1. Joints receiving IAI are also listed in Table 1. Global 
analyses refer to the whole group of 71 patients undergoing 
IAI in the present study. A sub-analysis of 23 patients under-
going hip IAI is presented separately. 
Whole group analyses 
Eighteen men and 52 women participated in the present study 
(mean 51.9 ± 13 years old). Twenty-four patients (33.8%) had 
IAI guided by fluoroscopy (FCG) while 47 others (66.2%) had 
the procedure performed under ultrasound imaging (USG). 
In this study, the data were distributed normally. At baseline, 
mean age for patients in the FCG was significantly higher 
than that observed for the USG (60.9 versus 48.2 years-old, 
respectively, P = 0.006). As shown in Table 2, groups did not 
differ in terms of age and gender.
Intra-group analyses demonstrated that both groups had 
significant improvement over time (P < 0.001). Intra-group 
analyses demonstrated that joint flexion improved at 4 weeks 
after intervention as compared to baseline only for patients 
in the FCG (P < 0.001).
VAS scores for both FCG and USG during the study as well 
as joint flexion are shown in Table 3. Mean VAS scores for pain 
at baseline were not different between the two groups (7.4 cm 
and 6.6 cm for FCG and USG, respectively). On the other hand, 
no significant difference was observed between groups as far 
as VAS for pain is considered. 
Table 1 – Injected joints: whole group analysis (n = 71).
IAI guided by 
fluoroscopy
IAI guided by 
ultrasound
Naviculocuneiforme (n) 0 1
Glenohumeral (n) 4 3
Acromioclavicular (n) 0 2
Hip (n) 12 11
Wrist (n) 1 30
Ankle (n) 5 0
First metacarpophalangeal (n) 1 0
Sacroiliac (n) 1 0
Total n % 24 (33.8) 47 (66.2)
Table 2 – Demographic and general characteristics: 
whole group (n = 71).
Group guided 
by FCG  
(n = 24)
Group guided 
by USG  
(n = 47)
P value
Age in years (± SD) 62 (16.9) 49 (10.8) 0.006
Gender (M/F) 8/16 10/36 0.292
Skin color (white/
no white)
12/9 32/12 0.141
Initial VAS for pain 
(± SD)
7.4 (2.2) 6.6 (1.9) 0.076
Initial joint flexion 
(± SD)
74.7° (29.3) 53.2° (28.3) 0.001
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Joint flexion measured at baseline was significantly dif-
ferent between groups. FCG patients had significantly high-
er mean joint flexion as compared to USG patients (74.7º ± 
29.3º vs. 53.2º ± 28.3º, respectively; P = 0,011). As shown in 
Table 3, inter-group analyses demonstrated that joint flexion 
improved significantly better in the FCG as compared to the 
USG (P < 0.001). The same trend was also observed when the 
percentage change for joint flexion was evaluated (P = 0.016).
A specific analysis of joints that had flexion improvement 
higher than 10% was also performed comparing fluoroscopy 
and ultrasound-guided procedures. The percentage of pa-
tients in the FCG who had joint flexion improvement higher 
than 10% (72.2% of the patients) was significantly higher than 
that seen for the USG (45.5% of the patients, P = 0.055).
Table 4 shows the results for Likert scale for improvement. 
About 8.3% of the patients in the FCG reported improvement 
as compared to 30.4% of the patients in the USG (P = 0.041); 
Accordingly, 16.7% of the patients in the FCG had no improve-
ment while the percentage of no improvement for the USG 
was only 2.2% (P = 0.044). Different results were found when 
Likert scale scores for improvement (better and much better) 
and worsening (worse and much worse) were counted togeth-
er. About 97.8% of the patients (N = 45) in the USG reported 
some improvement (better or much better) during the study 
as compared to about 75% of the patients (N = 18) in the FCG (P 
= 0.005). Accordingly, the percentage of unchanged patients in 
the FCG (20.8% - 5 patients) was significantly higher than that 
seen for the USG (2.2% - 1 patient) (P = 0.016).
Hip IAI analyses
A subanalysis of patients undergoing hip IAI under fluorosco-
py or ultrasound was performed as an attempt to homogenize 
the sample. As shown in Table 5, no statistically significant 
difference was observed between the two groups at baseline 
in terms of age, gender, race, VAS for pain and joint flexion.
Intra-group analyses demonstrated significant improve-
ment for VAS for pain and joint flexion in both groups, from 
baseline to the end of the study (P < 0.002).
In Table 6 data regarding VAS and joint flexion for both 
groups are presented. No significant difference was detected 
between groups. 
Differently from the data observed for the whole popula-
tion, inter-group analyses did not demonstrate any significant 
difference in joint flexion between fluoroscopy and ultra-
sound groups. There was a trend in favor of the FCG when the 
percentage change for joint flexion was evaluated but that did 
not reach statistical significance (P = 0.07).
Likert scale scores for improvement perception by the pa-
tient did not differ significantly between groups.
Discussion
IAI is a therapeutic option for the treatment of refractory 
synovitis, either chronic or acute, and of joints that are dif-
ficult to access. However, factors such as the method chosen 
to guide the procedure, good knowledge of the anatomical 
landmarks and the professional’s expertise, all interfere 
with the correct positioning of the needle and the success 
of the procedure.2
Table 3 – Visual analogue scale (VAS) for pain, joint 
flexion and percentage change for joint flexion between 
groups: whole group analysis (n = 71).
Fluoroscopy 
group (24)
Ultrasound 
group (47)
Intergroup P 
value
VAS for pain (± SD) 0.076
T0 (± SD) 7.4 (2.2) 6.6 (1.9)
T4 (±SD) 3.4 (2.8) 2.6 (2.3)
Intragroup P 
value
< 0.001 < 0.001
Joint flexion (± SD) < 0.001
T0 (±SD) 74.7° (29.3) 53.2° (28.3)
T4 (±SD) 96.0° (33.7) 56.8° (31.0)
< 0.001 0.074
Change for joint flexion (±SD) 0.016
T4 (±SD) 23.5° (46.1) 8.1° (27.7)
Anova; t-student.
Table 6 – Visual analogue scale (VAS) for pain, joint 
flexion and Percentage change for joint flexion between 
groups: hip sub-analysis (n =23).
FCG group  
(n = 12)
USG group  
(n = 11)
P value
VAS 0.753
T0 (± SD) 7.8 cm ± 1.6 7.6 cm ± 2.0
T4 (± SD) 3.4 cm ± 3.2 3.1 cm ± 2.3
Flexion 0.692
T0 (± SD) 70.0° (19.1) 82.7° (21.0)
T4 (± SD) 96.6° (19.4) 89.9° (23.6)
Chance for joint flexion 0.07
T4 (±SD) 39.0° (50) 10.0° (30.5)
Anova; t-Student.
Table 4 – Likert Scale between groups: whole group 
analysis (n = 71).
Fluoroscopy 
group
Ultrasound 
group
P value
Much worse (%) 1 (4.2) 0 (0) NS
Somewhat worse 
(%)
0 (0) 0 (0) NS
Unchanged (%) 4 (16.7) 1 (2.2) 0.044
Better (%) 2 (8.3) 14 (30.4) 0.041
Much better (%) 17 (70.8) 31 (67.4) NS
Chi square. NS, no significant.
Table 5 – Demographic characteristics: hip sub-analysis 
(n = 23).
FCG group  
(n = 12)
USG group  
(n = 11)
P value
 Age in years (+- SD) 60.6 (19.3) 50.5 (14.6) 0.187
 Gender (M/F) 7/5 7/4 1.000
Skin color (White/
no white)
6/4 5/6 0.762
SD, standard deviation. t-Student; Fisher’s exact test; chi square.
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IAI with corticosteroid has been used since the 50s, espe-
cially in the rheumatologists’ practice.8 Despite the routine 
use of the procedure, only a few randomized controlled tri-
als have been performed on the matter and most concepts 
have been raised from those rare studies. Some of these con-
cepts are well established, especially in the field of rheuma-
toid arthritis. It is known that triamcinolone hexacetonide is 
the most effective corticosteroid to be used to cause chemical 
synovectomy.6,9-16 Other studies have demonstrated that the 
use of intra-articular corticosteroid, either as monoarticular 
or polyarticular injection, is more effective and better toler-
ated than the systemic use of drugs.17,18 However, it has not 
been yet established in the literature, among other concepts, 
which dose of triamcinolone hexacetonide is the ideal to be 
used for each joint, the cost-effectiveness of IAI with radioiso-
topes or the cost-effectiveness of using imaging techniques to 
guide IAI and increase its accuracy.
There are several studies on the accuracy of IAI with con-
flicting results. Some authors argue that blind IAI conveys low 
accuracy even for approaches of the knee.19 Others have sug-
gested that blind IAI accuracy might be improved when the 
physician is well trained in the procedure. For these authors, 
the ankle is still the joint with the lowest accuracy for blind 
injection (77%).20 For some joints as the hip, the glenohumeral 
and interapophyseal joints, common sense has made imag-
ing techniques almost mandatory for injection approaches.
The use of imaging techniques to guide IAI allows for 
therapeutic and diagnostic procedures in deep joints and 
structures, the intra-articular use of radioisotopes and the 
appropriate approach for joint deformities.21 Of the various 
methods used to guide IAI, fluoroscopy and ultrasound are the 
more easily available for the clinician. The advantages of fluo-
roscopy have been listed: the approach of any joint, including 
axial, besides panoramic and direct visualization of the struc-
tures. Visualization of soft tissue, convenience and portability, 
and the lack of contrast and radiation in the procedure are 
recognized as advantages for the use of ultrasound.3,22-26
Fluoroscopy has been used for decades to address the 
intra-articular space.21,27 However, only a few studies have 
evaluated the effectiveness of fluoroscopy-guided IAI as com-
pared to blind procedures. Hegedus et al.28 have found that 
the effectiveness (pain and function) for glenohumeral IAI 
(103 shoulders) was not related to the accuracy of the proce-
dure as confirmed by fluoroscopy. Other colleagues29 have also 
found no difference in terms of effectiveness of periarticular 
corticosteroid injections of the trochanteric bursa when blind 
procedure was compared to fluoroscopy-guided intervention 
in 65 patients. The use of potent intra-articular corticoste-
roids (triamcinolone hexacetonide, for example) has been re-
stricted to fluoroscopic control in some Institutions. However, 
despite the practice, controlled studies are needed to estab-
lish the cost-effectiveness of fluoroscopy-guided IAI.
Ultrasound has become a very interesting tool increasingly 
used by clinicians as an extension of physical examination 
and also to guide diagnostic and therapeutic procedures. In 
rheumatology, ultrasound has become very useful for the de-
tection of subclinical synovitis and joint damage (bone ero-
sion) not detected by conventional X ray.2,30.
The use of non-ionizing technique, the low cost and por-
tability have made the ultrasound the best choice to guide 
muscle skeletal interventions.2,5,25,31 However, the size of the 
joint, the operator experience and patient obesity should 
be taken into consideration when choosing ultrasound.32,33 
Despite its usefulness to guide procedures and the grow-
ing interest of clinicians in the method, effectiveness stud-
ies comparing blind to ultrasound-guided IAI have presented 
conflicting results. Greater effectiveness has been reported 
for ultrasound-guided IAI or periarticular of the subacromial 
space,3 the plantar fascia,34 adhesive capsulitis35 and various 
types of appendicular joints.36 However, several other studies 
have found different results for the subacromial space5,37 and 
the wrist (radiocarpal joint).38
No studies have compared the effectiveness of ultrasound 
versus fluoroscopy-guided IAI. In a study with a different aim 
(evaluation of accuracy), it was observed that ultrasound was 
superior to fluoroscopy to guide the placement of the needle 
for infiltration of the piriformis muscle in 20 cadavers (95% 
accuracy for ultrasound versus 30% for fluoroscopy).39 In a 
sample of 25 shoulders undergoing IAI, Rutten et al.5 observed 
that ultrasound was better than fluoroscopy for accuracy, 
pain caused by the procedure (tolerance) and time to carry 
out the procedure. In that study, no prospective evaluation of 
effectiveness of IAI guided by the two methods is reported.
This is the first study to compare IAI with triamcinolone 
hexacetonide performed either under fluoroscopy or ultra-
sound having “effectiveness” (pain, goniometry and percep-
tion of improvement by the patient) as the main outcome. 
The variables chosen in the study are not only relevant for 
the clinical rheumatologist, but also easily measurable in a 
routine setting. In agreement with the uncontrolled experi-
ence of the authors, the present study demonstrated signifi-
cant improvement in joint pain and function in both groups 
after four weeks of the procedure. No significant difference 
was detected between groups in terms of joint pain.
Some important limitations proper to the design of our 
study need to be pointed out. In the first part of the study 
(Whole group analyses), significant heterogeneity of the in-
jected joints was observed in both groups and that hindered 
the comparison of some variables (as was the case for joint 
flexion). That was due to both the difficulty of addressing 
some joints with ultrasound and also the lower availability of 
fluoroscopy in some scenarios.
In spite of the low number of patients, the second part of 
the study (Hip IAI sub-analysis) had suitable homogeneity 
between groups at baseline. Because of non-randomization 
and the high number of wrists in the US group, sampling may 
have had a selection bias. Despite these many limitations, the 
present study displays a very good external validity and por-
trays the routine of a rheumatology service where interven-
tional procedures are performed on an outpatient care basis.
Hip analysis is particularly interesting given that this 
joint is not commonly approached blindly. In this analysis, 
differences between groups detected in the overall analysis 
in terms of joint flexion, percentage change of joint flexion 
and improvement according to the Likert scale were not con-
firmed. In other words, when homogeneity of the sample was 
reached, no significant difference in effectiveness was ob-
served between fluoroscopy and ultrasound-guided IAI. 
Our study demonstrated that in a homogeneous sample 
of patients with indication for IAI of the hip (refractory sy-
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novitis), fluoroscopy and ultrasound-guided procedures are 
equally effective. This finding needs further confirmation in 
studies involving a larger number of patients. Our results sug-
gest that the choice of either one or other method to guide 
IAI might be based on other variables such as cost, the physi-
cian’s skill in handling or the availability of the method, since 
their effectiveness is quite similar.
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